1. Montalescot G, Brieger D, Eagle KA, Anderson FA, Fitzgerald G, Lee MS, et al. Unprotected left main revascularization in patients with acute coronary syndromes. Eur Heart J 2009; 30: 2308 – 2317.
2. Pedrazzini GB, Radovanovic D, Vassalli G, Sürder D, Moccetti T, Eberli F, et al. Primary percutaneous coronary intervention for unprotected left main disease in patients with acute ST-segment elevation myocardial infarction: The AMIS (Acute Myocardial Infarction in Switzerland) plus registry experience. JACC Car- diovasc Interv 2011; 4: 627 – 633.
3. Sim DS, Ahn Y, Jeong MH, Kim YJ, Chae SC, Hong TJ, et al. Clinical outcome of unprotected left main coronary artery disease in patients with acute myocardial infarction. Int Heart J 2013; 54: 185 – 191.
4. Patel N, De Maria GL, Kassimis G, Rahimi K, Bennett D, Ludman P, et al. Outcomes after emergency percutaneous coro- nary intervention in patients with unprotected left main stem occlusion: The BCIS national audit of percutaneous coronary intervention 6-year experience. JACC Cardiovasc Interv 2014; 7: 969 – 980.
5. Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR, et al. 2014 AHA/ACC guideline for the manage- ment of patients with non-ST-elevation acute coronary syndromes: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Car- diol 2014; 64: e139 – e228.
6. O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, De Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiol 2013; 61: e78 – e140.
7. Holmes DR Jr, Berger PB, Hochman JS, Granger CB, Thompson TD, Califf RM, et al. Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation 1999; 100: 2067 – 2073.
8. Van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, et al. Contemporary management of cardiogenic shock: A Scientific Statement from the American Heart Associa- tion. Circulation 2017; 136: e232 – e268.
9. Ohya M, Kadota K, Toyofuku M, Morimoto T, Higami H, Fuku Y, et al. Long-term outcomes after stent implantation for left main coronary artery (from the Multicenter Assessing Optimal Percutaneous Coronary Intervention for Left Main Coronary Artery Stenting Registry). Am J Cardiol 2017; 119: 355 – 364.
10. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, Van Es GA, et al. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007; 115: 2344 – 2351.
11. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the bleeding academic research consortium. Circulation 2011; 123: 2736 – 2747.
12. Lee MS, Sillano D, Latib A, Chieffo A, Zoccai GB, Bhatia R, et al. Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug- eluting stents in patients with myocardial infarction. Catheter Cardiovasc Interv 2009; 73: 15 – 21.
13. Prasad SB, Whitbourn R, Malaiapan Y, Ahmar W, MacIsaac A, Meredith IT. Primary percutaneous coronary intervention for acute myocardial infarction caused by unprotected left main stem thrombosis. Catheter Cardiovasc Interv 2009; 73: 301 – 307.
14. Rodés-Cabau J, DeBlois J, Bertrand OF, Mohammadi S, Courtis J, Larose E, et al. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery dis- ease in octogenarians. Circulation 2008; 118: 2374 – 2381.
15. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery dis- ease. N Engl J Med 2009; 360: 961 – 972.
16. Shemin RJ. Coronary artery bypass grafting versus stenting for unprotected left main coronary artery disease: Where lies the body of proof? Circulation 2008; 118: 2326 – 2329.
17. Almudarra SS, Gale CP, Baxter PD, Fleming SJ, Brogan RA, Ludman PF, et al. Comparative outcomes after unprotected left main stem percutaneous coronary intervention: A national linked cohort study of 5,065 acute and elective cases from the BCIS reg- istry (British Cardiovascular Intervention Society). JACC Car- diovasc Interv 2014; 7: 717 – 730.
18. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012; 367: 1287 – 1296.
19. Prondzinsky R, Unverzagt S, Russ M, Lemm H, Swyter M, Wegener N, et al. Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: The prospective, randomized IABPshock trial. Shock 2012; 37: 378 – 384.
20. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP- SHOCK II): Final 12 month results of a randomised, open-label trial. Lancet 2013; 382: 1638 – 1645.
21. Ouweneel DM, Engstrom AE, Sjauw KD, Hirsch A, Hill JM, Gockel B, et al. Experience from a randomized controlled trial with Impella 2.5 versus IABPin STEMI patients with cardiogenic pre-shock: Lessons learned from the IMPRESS in STEMI trial. Int J Cardiol 2016; 202: 894 – 896.
22. Ouweneel DM, Eriksen E, Sjauw KD, van Dongen IM, Hirsch A, Packer EJS, et al. Percutaneous mechanical circulatory sup- port versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol 2017; 69: 278 – 287.
23. Engström AE, Cocchieri R, Driessen AH, Sjauw KD, Vis MM, Baan J, et al. The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and pro- found cardiogenic shock: The Academic Medical Center inten- sive care unit experience. Crit Care Med 2011; 39: 2072 – 2079.
24. Shiomi H, Nakagawa Y, Morimoto T, Furukawa Y, Nakano A, Shirai S, et al. Association of onset to balloon and door to bal- loon time with long term clinical outcome in patients with ST elevation acute myocardial infarction having primary percutane- ous coronary intervention: Observational study. BMJ 2012; 344: e3257.
25. Brodie BR, Gersh BJ, Stuckey T, Witzenbichler B, Guagliumi G, Peruga JZ, et al. When is door-to-balloon time critical?: Analysis from the HORIZONS-AMI (Harmonizing outcomes with revas- cularization and stents in acute myocardial infarction) and CADILLAC (Controlled abciximab and device investigation to lower late angioplasty complications) trials. J Am Coll Cardiol 2010; 56: 407 – 413.